Crossmark Global Holdings’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Buy |
12,002
+2,712
| +29% | +$593K | 0.04% | 358 |
|
|
2025
Q1 | $2.08M | Buy |
9,290
+1,413
| +18% | +$316K | 0.04% | 413 |
|
|
2024
Q4 | $2.58M | Buy |
7,877
+2,309
| +41% | +$757K | 0.05% | 336 |
|
|
2024
Q3 | $1.67M | Sell |
5,568
-312
| -5% | -$93.6K | 0.03% | 452 |
|
|
2024
Q2 | $1.94M | Buy |
5,880
+180
| +3% | +$59.3K | 0.04% | 412 |
|
|
2024
Q1 | $2.26M | Sell |
5,700
-704
| -11% | -$279K | 0.04% | 396 |
|
|
2023
Q4 | $2.26M | Sell |
6,404
-46
| -0.7% | -$16.2K | 0.05% | 370 |
|
|
2023
Q3 | $2.5M | Sell |
6,450
-520
| -7% | -$201K | 0.06% | 337 |
|
|
2023
Q2 | $2.55M | Sell |
6,970
-74
| -1% | -$27K | 0.05% | 350 |
|
|
2023
Q1 | $2.44M | Sell |
7,044
-2,540
| -27% | -$880K | 0.06% | 348 |
|
|
2022
Q4 | $2.26M | Buy |
9,584
+681
| +8% | +$160K | 0.06% | 360 |
|
|
2022
Q3 | $2.19M | Sell |
8,903
-399
| -4% | -$98.2K | 0.06% | 331 |
|
|
2022
Q2 | $2.81M | Buy |
9,302
+470
| +5% | +$142K | 0.07% | 293 |
|
|
2022
Q1 | $3.63M | Sell |
8,832
-250
| -3% | -$103K | 0.08% | 266 |
|
|
2021
Q4 | $4.26M | Sell |
9,082
-3,810
| -30% | -$1.79M | 0.09% | 225 |
|
|
2021
Q3 | $5.47M | Sell |
12,892
-837
| -6% | -$355K | 0.13% | 177 |
|
|
2021
Q2 | $4.93M | Sell |
13,729
-3,420
| -20% | -$1.23M | 0.12% | 186 |
|
|
2021
Q1 | $4.83M | Sell |
17,149
-1,530
| -8% | -$431K | 0.12% | 186 |
|
|
2020
Q4 | $5.29M | Buy |
18,679
+5,480
| +42% | +$1.55M | 0.13% | 177 |
|
|
2020
Q3 | $3.63M | Buy |
13,199
+360
| +3% | +$99K | 0.1% | 218 |
|
|
2020
Q2 | $2.92M | Buy |
12,839
+5,579
| +77% | +$1.27M | 0.09% | 261 |
|
|
2020
Q1 | $1.11M | Buy |
7,260
+20
| +0.3% | +$3.04K | 0.04% | 440 |
|
|
2019
Q4 | $1.09M | Buy |
7,240
+260
| +4% | +$39.1K | 0.03% | 535 |
|
|
2019
Q3 | $990K | Sell |
6,980
-170
| -2% | -$24.1K | 0.03% | 536 |
|
|
2019
Q2 | $895K | Sell |
7,150
-486
| -6% | -$60.8K | 0.03% | 578 |
|
|
2019
Q1 | $841K | Buy |
7,636
+160
| +2% | +$17.6K | 0.02% | 600 |
|
|
2018
Q4 | $733K | Sell |
7,476
-960
| -11% | -$94.1K | 0.02% | 618 |
|
|
2018
Q3 | $1.04M | Sell |
8,436
-600
| -7% | -$74.1K | 0.03% | 595 |
|
|
2018
Q2 | $897K | Sell |
9,036
-110
| -1% | -$10.9K | 0.02% | 640 |
|
|
2018
Q1 | $808K | Sell |
9,146
-1,660
| -15% | -$147K | 0.02% | 682 |
|
|
2017
Q4 | $1.07M | Buy |
10,806
+326
| +3% | +$32.2K | 0.03% | 625 |
|
|
2017
Q3 | $1.01M | Buy |
+10,480
| New | +$1.01M | 0.03% | 608 |
|
|
2016
Q3 | $1.01M | Buy |
+10,480
| New | +$1.01M | 0.03% | 608 |
|